Letter to the Editor

Vol. 49 No. 1 (2025): Cerrahpaşa Medical Journal
DOI: https://doi.org/10.5152/cjm.2025.25012

Article Sidebar

Full Text PDF
Published: Mar 27, 2025

Main Article Content

Zeynep Altan Ferhatoğlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
https://orcid.org/0000-0003-3090-656X
Tuğba Kevser Uzunçakmak
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
https://orcid.org/0000-0001-8057-3463
Görkem Mutlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
https://orcid.org/0009-0009-7013-3929

The Use of High-Dose Omalizumab in the Treatment of Resistant Chronic Urticaria: A Case Series

Main Article Content

Zeynep Altan Ferhatoğlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
https://orcid.org/0000-0003-3090-656X
Tuğba Kevser Uzunçakmak
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
https://orcid.org/0000-0001-8057-3463
Görkem Mutlu
Department of Dermatology and Venereal Disease, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
https://orcid.org/0009-0009-7013-3929

Abstract

Cite this article as: Ferhatoğlu ZA, Uzunçakmak TK, Mutlu G. The use of high-dose omalizumab in the treatment of resistant chronic urticaria: a case series. Cerrahpaşa Med J. 2025, 49, 0012, doi: 10.5152/cjm.2025.25012

Article Details